10 prospects
| Company | Tier ↑ | Status | Size | Growth | Broker | Contact |
|---|---|---|---|---|---|---|
| Hill ResearchAI / Clinical Trials / Life Sciences | Hot | Qualified | 16 | +30.0% | None found | Dr. Louise Liu |
| Hengrui USA / Luzsana BiotechnologyPharma / Oncology & Immunology | Hot | Qualified | 19 | +36.8% | None found | Chris Bosworth |
| Kanvas BiosciencesBiotech / Microbiome Therapeutics | Hot | Qualified | 39 | +37.9% | None found | Matthew P. Cheng |
| Thea EnergyFusion Energy / Deep Tech | Hot | Qualified | 106 | +100.0% | None found | Brian Berzin |
| ArrePathBiotech / Anti-Infectives (AI-driven) | Hot | Qualified | 15 | +40.0% | None found | Kevin Krause |
| ComputomicAI / Data Infrastructure / Consulting | Strong | Qualified | 53 | +114.0% | Landlord rep | Sanjeev Agarwalla |
| Latent AIDefense AI / Edge Computing | Strong | Qualified | 44 | +50.0% | Landlord rep | Jags Kandasamy |
| Antigenix TherapeuticsBiotech / ADC Oncology | Strong | Qualified | 15 | +30.0% | None found | Squire Servance |
| Ascendis PharmaRare Endocrine Diseases / Biopharma | Strong | Qualified | 100 | +100.0% | Likely has broker | Jay Donovan Wu |
| PaceControls / PACE AIAI / CleanTech / Energy | Monitor | Qualified | 5 | — | None found | Thomas Mills |